Nine reasons why ecstasy is not quite what it used to be.
International Journal of Drug Policy November 20, 2017 Jane Mounteney, Paul J Griffiths, Alessandra Bo et al.
This paper explores the recent resurgence in use of ecstasy/MDMA in Europe and highlights keys areas of continuity and divergence between the ecstasy market of the 1990s and the current MDMA market. Based on a scoping study involving a targeted multi-source data collection exercise on MDMA, it highlights nine areas that have undergone some level of change, linked with both supply and demand for...
DOI: 10.1016/j.drugpo.2017.09.016 (opens in new tab)
Full text (opens in new tab)
MDMA
Ecstasy
Humans
Substance-related disorders
+5